Skip to content
Tech News
clear
Topics: Today This Week This Month This Year

Anthropic revokes paid Claude Max accounts citing vague 'suspicious signals'

A long-time paying Anthropic customer on the $200/month Claude Max plan reports abrupt account termination via a form email citing 'suspicious signals' tied to a Usage Policy violation, with no specific reason given. The user says another Max subscriber elsewhere was banned right after paying, and the only appeal route is an automated in-product form rather than contact with a person.

Study identifies biomarkers linked to better outcomes from perioperative immunotherapy in lung cancer

Researchers report findings on biological markers that correlate with improved patient outcomes when immune-based therapies are used before and after surgery for lung cancer. The publication, appearing on Nature's platform, outlines how certain biomarkers may help predict which patients respond best to this perioperative treatment approach.

New AI tool CW-Net explains self-driving car decisions using human concepts

Researchers led by Kenny et al. published in Nature a system called Concept-Wrapper Network (CW-Net) that opens up the 'black box' of autonomous vehicle decision-making. Instead of opaque outputs, CW-Net translates a car's reasoning into human-understandable concepts, such as recognizing a pedestrian or obstacle, so passengers can better anticipate its next move. Testing showed this approach improved people's ability to predict vehicle behavior even in cases where the car made errors.

Revlimid successor daraxonrasib shrinks tumors in early lung cancer trial

A week after its US approval for advanced pancreatic cancer, the drug daraxonrasib has shown early promise against non-small cell lung cancer, the most common form of the disease. In a small trial published in the New England Journal of Medicine, tumors shrank in over 30% of patients whose cancers carried mutations in RAS family proteins and who had already failed other treatments. A larger randomized trial comparing daraxonrasib to standard chemotherapy is now underway.

Cambridge sociologist Jason Arday dies after misconduct claims and media scrutiny

Jason Arday, professor of sociology of education at the University of Cambridge, resigned on 5 August after facing allegations of research misconduct and what he described as relentless public attack going beyond normal academic criticism. Nine days later, following sustained media coverage of his professional and personal life, he died. Nature's editorial calls for reflection on how universities handle misconduct investigations and how the press covers such cases, particularly given the racism present in much of the coverage.

Nature study: GLP-1 obesity drug extended lifespan in older female mice

Researchers publishing in Nature on September 2 found that older female mice given a GLP-1 obesity drug lived longer than untreated mice and showed slower onset of several biological markers linked to aging. The finding builds on earlier mouse studies suggesting GLP-1 medications, typically used for obesity and type 2 diabetes, may have broader anti-aging effects beyond weight loss.

Research funding surges into long COVID and related post-infection syndromes

Scientists are accelerating efforts to understand why some infections trigger lasting illnesses such as long COVID and ME/CFS. A 2024 estimate put the global number of long COVID cases at 400 million, costing roughly $1 trillion annually, spurring governments including the US and Germany to commit over $1.7 billion combined toward research into post-infection diseases.

Nature Futures publishes speculative short story 'City of Slop' about AI-run cities

Nature's Futures section ran a piece of short science fiction depicting a community living on the fringes of AI-controlled cities that have become dysfunctional and unpredictable, with one city literally rearranging itself and threatening two scavengers, Kyle and Emma, who rely on a hand-drawn map to survive. The story imagines a world where humans ceded urban management to AI systems that have since decayed into unstable, self-altering environments.

Today's top topics: openai anthropic apple google ai agents ai safety android authority artificial intelligence gemini iphone 18 pro
Browse all topics →  ·  Today's trending topics →